Physician

Bertram David Kaplan, M.D.

According to 2025 Medicare claims, Bertram Kaplan, M.D. (NPI: 1548238348) practices dermatology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from Crittenden, AR. This provider's primary affiliated billing organization is BERTRAM D KAPLAN MD PLLC (NPI: 1023410941; TIN: 471627779) and primary practice location at 38119-4823.

Kaplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 409 traditional Medicare patients, billed 2,799 HCPCS/CPT codes, and received $84,433 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,759 prescription claims across 558 beneficiaries totaling $71,223 in drug costs, led by Betamethasone Valerate (Betamethasone Valerate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $267,315 to $84,433. Similarly, Part D prescription costs have declined steadily, from $177,608 to $71,223. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$134K$267K2015 Medicare payment: $267,315 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $216,223 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $210,732 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $198,969 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $212,056 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $178,632 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $181,149 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $154,945 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $131,269 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $84,433 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1478,548$267,315
20161,0127,332$216,223
20179777,120$210,732
20189206,497$198,969
20198996,355$212,056
20207905,008$178,632
20217154,696$181,149
20226364,109$154,945
20235403,740$131,269
20244092,799$84,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$89K$178K2015 Drug cost: $177,608 (USD; Tot_Drug_Cst)2016 Drug cost: $147,061 (USD; Tot_Drug_Cst)2017 Drug cost: $133,405 (USD; Tot_Drug_Cst)2018 Drug cost: $126,238 (USD; Tot_Drug_Cst)2019 Drug cost: $119,774 (USD; Tot_Drug_Cst)2020 Drug cost: $110,737 (USD; Tot_Drug_Cst)2021 Drug cost: $92,062 (USD; Tot_Drug_Cst)2022 Drug cost: $112,307 (USD; Tot_Drug_Cst)2023 Drug cost: $108,507 (USD; Tot_Drug_Cst)2024 Drug cost: $71,223 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155652,357$177,608
20165492,366$147,061
20175782,441$133,405
20186022,684$126,238
20196472,871$119,774
20206112,798$110,737
20216082,855$92,062
20226033,150$112,307
20236403,288$108,507
20245582,759$71,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth152197$57
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more227492$50
17000Destruction of precancer skin growth, 1 growth119199$33
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more124233$32
17003Destruction of precancer skin growth, 2-14 growths101557$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Betamethasone ValerateBetamethasone Valerate50513,876$14,863
Mometasone FuroateMometasone Furoate51813,345$9,976
Clobetasol PropionateClobetasol Propionate1775,015$9,612
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc752,041$5,926
Minocycline HclMinocycline Hcl1905,223$4,189

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Bertram David Kaplan, M.D.?

Tedicare shows public-source Medicare data for Bertram David Kaplan, M.D. (NPI 1548238348), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bertram David Kaplan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bertram David Kaplan, M.D.?

Bertram David Kaplan, M.D. is linked to BERTRAM D KAPLAN MD PLLC (billing NPI 1023410941) in the available physician profile data.

Does Bertram David Kaplan, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.